AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2013
Mar 27, 2013
30826_dirs_2013-03-27_82a36d03-2003-4e7f-b0c6-771097737956.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2013-03-26
Reporting Person: HERLIHY WALTER C (Director, PRESIDENT, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-03-26 | Common Stock | M | 65000 | $5.51 | Acquired | 566898 | Direct |
| 2013-03-26 | Common Stock | F | 51982 | $6.89 | Disposed | 514916 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-03-26 | Stock Option (Right to Buy) | $5.51 | M | 65000 | Disposed | 2013-04-23 | Common Stock (65000) | Direct |
Footnotes
F1: Payment made via forfeiture of 51,982 shares of Common Stock valued at the Closing Price of $6.89 on March 26, 2013.
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23